The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oxcarbazepine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Oxcarbazepine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oxcarbazepine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pediatric Use (Aged 2-4 years, 4-16 years) accounting for % of the Oxcarbazepine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets (150mg, 300mg, 600mg) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oxcarbazepine include Novartis (Trileptal), Supernus Pharmaceuticals (Oxtellar XR), Sun Pharm, Ranbaxy Pharmaceuticals, and Jubilant Generics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oxcarbazepine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets (150mg, 300mg, 600mg)
Oral Suspension
Market segment by Application can be divided into
Pediatric Use (Aged 2-4 years, 4-16 years)
Adult Use
The key market players for global Oxcarbazepine market are listed below:
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Sun Pharm
Ranbaxy Pharmaceuticals
Jubilant Generics
Taro Pharmaceuticals
Mylan
Stada Group
Glenmark Pharmaceuticals
ANI Pharmaceuticals
Teva Pharmaceutical
Roxane Laboratories
Nobelpharma
Apotex
Nexgen pharma
Amneal Pharmaceuticals
Hikma Pharmaceuticals
Jamp Pharma
Neuraxpharm
Orion Corporation
Sihuan Pharm
Humanwell Healthcare
Huikang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oxcarbazepine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oxcarbazepine, with price, sales, revenue and global market share of Oxcarbazepine from 2019 to 2022.
Chapter 3, the Oxcarbazepine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oxcarbazepine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oxcarbazepine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oxcarbazepine.
Chapter 13, 14, and 15, to describe Oxcarbazepine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Oxcarbazepine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oxcarbazepine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pediatric Use (Aged 2-4 years, 4-16 years) accounting for % of the Oxcarbazepine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets (150mg, 300mg, 600mg) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oxcarbazepine include Novartis (Trileptal), Supernus Pharmaceuticals (Oxtellar XR), Sun Pharm, Ranbaxy Pharmaceuticals, and Jubilant Generics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oxcarbazepine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets (150mg, 300mg, 600mg)
Oral Suspension
Market segment by Application can be divided into
Pediatric Use (Aged 2-4 years, 4-16 years)
Adult Use
The key market players for global Oxcarbazepine market are listed below:
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Sun Pharm
Ranbaxy Pharmaceuticals
Jubilant Generics
Taro Pharmaceuticals
Mylan
Stada Group
Glenmark Pharmaceuticals
ANI Pharmaceuticals
Teva Pharmaceutical
Roxane Laboratories
Nobelpharma
Apotex
Nexgen pharma
Amneal Pharmaceuticals
Hikma Pharmaceuticals
Jamp Pharma
Neuraxpharm
Orion Corporation
Sihuan Pharm
Humanwell Healthcare
Huikang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oxcarbazepine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oxcarbazepine, with price, sales, revenue and global market share of Oxcarbazepine from 2019 to 2022.
Chapter 3, the Oxcarbazepine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oxcarbazepine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oxcarbazepine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oxcarbazepine.
Chapter 13, 14, and 15, to describe Oxcarbazepine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Oxcarbazepine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oxcarbazepine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablets (150mg, 300mg, 600mg)
1.2.3 Oral Suspension
1.3 Market Analysis by Application
1.3.1 Overview: Global Oxcarbazepine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pediatric Use (Aged 2-4 years, 4-16 years)
1.3.3 Adult Use
1.4 Global Oxcarbazepine Market Size & Forecast
1.4.1 Global Oxcarbazepine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oxcarbazepine Sales in Volume (2017-2028)
1.4.3 Global Oxcarbazepine Price (2017-2028)
1.5 Global Oxcarbazepine Production Capacity Analysis
1.5.1 Global Oxcarbazepine Total Production Capacity (2017-2028)
1.5.2 Global Oxcarbazepine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oxcarbazepine Market Drivers
1.6.2 Oxcarbazepine Market Restraints
1.6.3 Oxcarbazepine Trends Analysis
2 Manufacturers Profiles
2.1 Novartis (Trileptal)
2.1.1 Novartis (Trileptal) Details
2.1.2 Novartis (Trileptal) Major Business
2.1.3 Novartis (Trileptal) Oxcarbazepine Product and Services
2.1.4 Novartis (Trileptal) Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Supernus Pharmaceuticals (Oxtellar XR)
2.2.1 Supernus Pharmaceuticals (Oxtellar XR) Details
2.2.2 Supernus Pharmaceuticals (Oxtellar XR) Major Business
2.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product and Services
2.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sun Pharm
2.3.1 Sun Pharm Details
2.3.2 Sun Pharm Major Business
2.3.3 Sun Pharm Oxcarbazepine Product and Services
2.3.4 Sun Pharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ranbaxy Pharmaceuticals
2.4.1 Ranbaxy Pharmaceuticals Details
2.4.2 Ranbaxy Pharmaceuticals Major Business
2.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Product and Services
2.4.4 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Jubilant Generics
2.5.1 Jubilant Generics Details
2.5.2 Jubilant Generics Major Business
2.5.3 Jubilant Generics Oxcarbazepine Product and Services
2.5.4 Jubilant Generics Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Taro Pharmaceuticals
2.6.1 Taro Pharmaceuticals Details
2.6.2 Taro Pharmaceuticals Major Business
2.6.3 Taro Pharmaceuticals Oxcarbazepine Product and Services
2.6.4 Taro Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Oxcarbazepine Product and Services
2.7.4 Mylan Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Stada Group
2.8.1 Stada Group Details
2.8.2 Stada Group Major Business
2.8.3 Stada Group Oxcarbazepine Product and Services
2.8.4 Stada Group Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Glenmark Pharmaceuticals
2.9.1 Glenmark Pharmaceuticals Details
2.9.2 Glenmark Pharmaceuticals Major Business
2.9.3 Glenmark Pharmaceuticals Oxcarbazepine Product and Services
2.9.4 Glenmark Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 ANI Pharmaceuticals
2.10.1 ANI Pharmaceuticals Details
2.10.2 ANI Pharmaceuticals Major Business
2.10.3 ANI Pharmaceuticals Oxcarbazepine Product and Services
2.10.4 ANI Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business
2.11.3 Teva Pharmaceutical Oxcarbazepine Product and Services
2.11.4 Teva Pharmaceutical Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Roxane Laboratories
2.12.1 Roxane Laboratories Details
2.12.2 Roxane Laboratories Major Business
2.12.3 Roxane Laboratories Oxcarbazepine Product and Services
2.12.4 Roxane Laboratories Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Nobelpharma
2.13.1 Nobelpharma Details
2.13.2 Nobelpharma Major Business
2.13.3 Nobelpharma Oxcarbazepine Product and Services
2.13.4 Nobelpharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Apotex
2.14.1 Apotex Details
2.14.2 Apotex Major Business
2.14.3 Apotex Oxcarbazepine Product and Services
2.14.4 Apotex Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Nexgen pharma
2.15.1 Nexgen pharma Details
2.15.2 Nexgen pharma Major Business
2.15.3 Nexgen pharma Oxcarbazepine Product and Services
2.15.4 Nexgen pharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Amneal Pharmaceuticals
2.16.1 Amneal Pharmaceuticals Details
2.16.2 Amneal Pharmaceuticals Major Business
2.16.3 Amneal Pharmaceuticals Oxcarbazepine Product and Services
2.16.4 Amneal Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Hikma Pharmaceuticals
2.17.1 Hikma Pharmaceuticals Details
2.17.2 Hikma Pharmaceuticals Major Business
2.17.3 Hikma Pharmaceuticals Oxcarbazepine Product and Services
2.17.4 Hikma Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Jamp Pharma
2.18.1 Jamp Pharma Details
2.18.2 Jamp Pharma Major Business
2.18.3 Jamp Pharma Oxcarbazepine Product and Services
2.18.4 Jamp Pharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Neuraxpharm
2.19.1 Neuraxpharm Details
2.19.2 Neuraxpharm Major Business
2.19.3 Neuraxpharm Oxcarbazepine Product and Services
2.19.4 Neuraxpharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Orion Corporation
2.20.1 Orion Corporation Details
2.20.2 Orion Corporation Major Business
2.20.3 Orion Corporation Oxcarbazepine Product and Services
2.20.4 Orion Corporation Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Sihuan Pharm
2.21.1 Sihuan Pharm Details
2.21.2 Sihuan Pharm Major Business
2.21.3 Sihuan Pharm Oxcarbazepine Product and Services
2.21.4 Sihuan Pharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Humanwell Healthcare
2.22.1 Humanwell Healthcare Details
2.22.2 Humanwell Healthcare Major Business
2.22.3 Humanwell Healthcare Oxcarbazepine Product and Services
2.22.4 Humanwell Healthcare Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Huikang Pharmaceutical
2.23.1 Huikang Pharmaceutical Details
2.23.2 Huikang Pharmaceutical Major Business
2.23.3 Huikang Pharmaceutical Oxcarbazepine Product and Services
2.23.4 Huikang Pharmaceutical Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oxcarbazepine Breakdown Data by Manufacturer
3.1 Global Oxcarbazepine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oxcarbazepine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oxcarbazepine
3.4 Market Concentration Rate
3.4.1 Top 3 Oxcarbazepine Manufacturer Market Share in 2021
3.4.2 Top 6 Oxcarbazepine Manufacturer Market Share in 2021
3.5 Global Oxcarbazepine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oxcarbazepine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oxcarbazepine Market Size by Region
4.1.1 Global Oxcarbazepine Sales in Volume by Region (2017-2028)
4.1.2 Global Oxcarbazepine Revenue by Region (2017-2028)
4.2 North America Oxcarbazepine Revenue (2017-2028)
4.3 Europe Oxcarbazepine Revenue (2017-2028)
4.4 Asia-Pacific Oxcarbazepine Revenue (2017-2028)
4.5 South America Oxcarbazepine Revenue (2017-2028)
4.6 Middle East and Africa Oxcarbazepine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oxcarbazepine Sales in Volume by Type (2017-2028)
5.2 Global Oxcarbazepine Revenue by Type (2017-2028)
5.3 Global Oxcarbazepine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oxcarbazepine Sales in Volume by Application (2017-2028)
6.2 Global Oxcarbazepine Revenue by Application (2017-2028)
6.3 Global Oxcarbazepine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oxcarbazepine Sales by Type (2017-2028)
7.2 North America Oxcarbazepine Sales by Application (2017-2028)
7.3 North America Oxcarbazepine Market Size by Country
7.3.1 North America Oxcarbazepine Sales in Volume by Country (2017-2028)
7.3.2 North America Oxcarbazepine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oxcarbazepine Sales by Type (2017-2028)
8.2 Europe Oxcarbazepine Sales by Application (2017-2028)
8.3 Europe Oxcarbazepine Market Size by Country
8.3.1 Europe Oxcarbazepine Sales in Volume by Country (2017-2028)
8.3.2 Europe Oxcarbazepine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oxcarbazepine Sales by Type (2017-2028)
9.2 Asia-Pacific Oxcarbazepine Sales by Application (2017-2028)
9.3 Asia-Pacific Oxcarbazepine Market Size by Region
9.3.1 Asia-Pacific Oxcarbazepine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oxcarbazepine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oxcarbazepine Sales by Type (2017-2028)
10.2 South America Oxcarbazepine Sales by Application (2017-2028)
10.3 South America Oxcarbazepine Market Size by Country
10.3.1 South America Oxcarbazepine Sales in Volume by Country (2017-2028)
10.3.2 South America Oxcarbazepine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oxcarbazepine Sales by Type (2017-2028)
11.2 Middle East & Africa Oxcarbazepine Sales by Application (2017-2028)
11.3 Middle East & Africa Oxcarbazepine Market Size by Country
11.3.1 Middle East & Africa Oxcarbazepine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oxcarbazepine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oxcarbazepine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oxcarbazepine
12.3 Oxcarbazepine Production Process
12.4 Oxcarbazepine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oxcarbazepine Typical Distributors
13.3 Oxcarbazepine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Oxcarbazepine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oxcarbazepine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis (Trileptal) Basic Information, Manufacturing Base and Competitors
Table 4. Novartis (Trileptal) Major Business
Table 5. Novartis (Trileptal) Oxcarbazepine Product and Services
Table 6. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Supernus Pharmaceuticals (Oxtellar XR) Basic Information, Manufacturing Base and Competitors
Table 8. Supernus Pharmaceuticals (Oxtellar XR) Major Business
Table 9. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product and Services
Table 10. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sun Pharm Basic Information, Manufacturing Base and Competitors
Table 12. Sun Pharm Major Business
Table 13. Sun Pharm Oxcarbazepine Product and Services
Table 14. Sun Pharm Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ranbaxy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Ranbaxy Pharmaceuticals Major Business
Table 17. Ranbaxy Pharmaceuticals Oxcarbazepine Product and Services
Table 18. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 20. Jubilant Generics Major Business
Table 21. Jubilant Generics Oxcarbazepine Product and Services
Table 22. Jubilant Generics Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Taro Pharmaceuticals Major Business
Table 25. Taro Pharmaceuticals Oxcarbazepine Product and Services
Table 26. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Mylan Basic Information, Manufacturing Base and Competitors
Table 28. Mylan Major Business
Table 29. Mylan Oxcarbazepine Product and Services
Table 30. Mylan Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Stada Group Basic Information, Manufacturing Base and Competitors
Table 32. Stada Group Major Business
Table 33. Stada Group Oxcarbazepine Product and Services
Table 34. Stada Group Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Glenmark Pharmaceuticals Major Business
Table 37. Glenmark Pharmaceuticals Oxcarbazepine Product and Services
Table 38. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. ANI Pharmaceuticals Major Business
Table 41. ANI Pharmaceuticals Oxcarbazepine Product and Services
Table 42. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceutical Major Business
Table 45. Teva Pharmaceutical Oxcarbazepine Product and Services
Table 46. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Roxane Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. Roxane Laboratories Major Business
Table 49. Roxane Laboratories Oxcarbazepine Product and Services
Table 50. Roxane Laboratories Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Nobelpharma Basic Information, Manufacturing Base and Competitors
Table 52. Nobelpharma Major Business
Table 53. Nobelpharma Oxcarbazepine Product and Services
Table 54. Nobelpharma Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Apotex Basic Information, Manufacturing Base and Competitors
Table 56. Apotex Major Business
Table 57. Apotex Oxcarbazepine Product and Services
Table 58. Apotex Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Nexgen pharma Basic Information, Manufacturing Base and Competitors
Table 60. Nexgen pharma Major Business
Table 61. Nexgen pharma Oxcarbazepine Product and Services
Table 62. Nexgen pharma Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Amneal Pharmaceuticals Major Business
Table 65. Amneal Pharmaceuticals Oxcarbazepine Product and Services
Table 66. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Hikma Pharmaceuticals Major Business
Table 69. Hikma Pharmaceuticals Oxcarbazepine Product and Services
Table 70. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 72. Jamp Pharma Major Business
Table 73. Jamp Pharma Oxcarbazepine Product and Services
Table 74. Jamp Pharma Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Neuraxpharm Basic Information, Manufacturing Base and Competitors
Table 76. Neuraxpharm Major Business
Table 77. Neuraxpharm Oxcarbazepine Product and Services
Table 78. Neuraxpharm Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 80. Orion Corporation Major Business
Table 81. Orion Corporation Oxcarbazepine Product and Services
Table 82. Orion Corporation Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Sihuan Pharm Basic Information, Manufacturing Base and Competitors
Table 84. Sihuan Pharm Major Business
Table 85. Sihuan Pharm Oxcarbazepine Product and Services
Table 86. Sihuan Pharm Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 88. Humanwell Healthcare Major Business
Table 89. Humanwell Healthcare Oxcarbazepine Product and Services
Table 90. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Huikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Huikang Pharmaceutical Major Business
Table 93. Huikang Pharmaceutical Oxcarbazepine Product and Services
Table 94. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Global Oxcarbazepine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Unit)
Table 96. Global Oxcarbazepine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 97. Market Position of Manufacturers in Oxcarbazepine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 98. Global Oxcarbazepine Production Capacity by Company, (M Unit): 2020 VS 2021
Table 99. Head Office and Oxcarbazepine Production Site of Key Manufacturer
Table 100. Oxcarbazepine New Entrant and Capacity Expansion Plans
Table 101. Oxcarbazepine Mergers & Acquisitions in the Past Five Years
Table 102. Global Oxcarbazepine Sales by Region (2017-2022) & (M Unit)
Table 103. Global Oxcarbazepine Sales by Region (2023-2028) & (M Unit)
Table 104. Global Oxcarbazepine Revenue by Region (2017-2022) & (USD Million)
Table 105. Global Oxcarbazepine Revenue by Region (2023-2028) & (USD Million)
Table 106. Global Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 107. Global Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 108. Global Oxcarbazepine Revenue by Type (2017-2022) & (USD Million)
Table 109. Global Oxcarbazepine Revenue by Type (2023-2028) & (USD Million)
Table 110. Global Oxcarbazepine Price by Type (2017-2022) & (USD/Unit)
Table 111. Global Oxcarbazepine Price by Type (2023-2028) & (USD/Unit)
Table 112. Global Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 113. Global Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 114. Global Oxcarbazepine Revenue by Application (2017-2022) & (USD Million)
Table 115. Global Oxcarbazepine Revenue by Application (2023-2028) & (USD Million)
Table 116. Global Oxcarbazepine Price by Application (2017-2022) & (USD/Unit)
Table 117. Global Oxcarbazepine Price by Application (2023-2028) & (USD/Unit)
Table 118. North America Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
Table 119. North America Oxcarbazepine Sales by Country (2023-2028) & (M Unit)
Table 120. North America Oxcarbazepine Revenue by Country (2017-2022) & (USD Million)
Table 121. North America Oxcarbazepine Revenue by Country (2023-2028) & (USD Million)
Table 122. North America Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 123. North America Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 124. North America Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 125. North America Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 126. Europe Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
Table 127. Europe Oxcarbazepine Sales by Country (2023-2028) & (M Unit)
Table 128. Europe Oxcarbazepine Revenue by Country (2017-2022) & (USD Million)
Table 129. Europe Oxcarbazepine Revenue by Country (2023-2028) & (USD Million)
Table 130. Europe Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 131. Europe Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 132. Europe Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 133. Europe Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 134. Asia-Pacific Oxcarbazepine Sales by Region (2017-2022) & (M Unit)
Table 135. Asia-Pacific Oxcarbazepine Sales by Region (2023-2028) & (M Unit)
Table 136. Asia-Pacific Oxcarbazepine Revenue by Region (2017-2022) & (USD Million)
Table 137. Asia-Pacific Oxcarbazepine Revenue by Region (2023-2028) & (USD Million)
Table 138. Asia-Pacific Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 139. Asia-Pacific Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 140. Asia-Pacific Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 141. Asia-Pacific Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 142. South America Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
Table 143. South America Oxcarbazepine Sales by Country (2023-2028) & (M Unit)
Table 144. South America Oxcarbazepine Revenue by Country (2017-2022) & (USD Million)
Table 145. South America Oxcarbazepine Revenue by Country (2023-2028) & (USD Million)
Table 146. South America Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 147. South America Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 148. South America Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 149. South America Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 150. Middle East & Africa Oxcarbazepine Sales by Region (2017-2022) & (M Unit)
Table 151. Middle East & Africa Oxcarbazepine Sales by Region (2023-2028) & (M Unit)
Table 152. Middle East & Africa Oxcarbazepine Revenue by Region (2017-2022) & (USD Million)
Table 153. Middle East & Africa Oxcarbazepine Revenue by Region (2023-2028) & (USD Million)
Table 154. Middle East & Africa Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 155. Middle East & Africa Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 156. Middle East & Africa Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 157. Middle East & Africa Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 158. Oxcarbazepine Raw Material
Table 159. Key Manufacturers of Oxcarbazepine Raw Materials
Table 160. Direct Channel Pros & Cons
Table 161. Indirect Channel Pros & Cons
Table 162. Oxcarbazepine Typical Distributors
Table 163. Oxcarbazepine Typical Customers
List of Figures
Figure 1. Oxcarbazepine Picture
Figure 2. Global Oxcarbazepine Revenue Market Share by Type in 2021
Figure 3. Tablets (150mg, 300mg, 600mg)
Figure 4. Oral Suspension
Figure 5. Global Oxcarbazepine Revenue Market Share by Application in 2021
Figure 6. Pediatric Use (Aged 2-4 years, 4-16 years)
Figure 7. Adult Use
Figure 8. Global Oxcarbazepine Revenue, (USD Million) & (M Unit): 2017 & 2021 & 2028
Figure 9. Global Oxcarbazepine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Oxcarbazepine Sales (2017-2028) & (M Unit)
Figure 11. Global Oxcarbazepine Price (2017-2028) & (USD/Unit)
Figure 12. Global Oxcarbazepine Production Capacity (2017-2028) & (M Unit)
Figure 13. Global Oxcarbazepine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Oxcarbazepine Market Drivers
Figure 15. Oxcarbazepine Market Restraints
Figure 16. Oxcarbazepine Market Trends
Figure 17. Global Oxcarbazepine Sales Market Share by Manufacturer in 2021
Figure 18. Global Oxcarbazepine Revenue Market Share by Manufacturer in 2021
Figure 19. Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Oxcarbazepine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Oxcarbazepine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Oxcarbazepine Sales Market Share by Region (2017-2028)
Figure 23. Global Oxcarbazepine Revenue Market Share by Region (2017-2028)
Figure 24. North America Oxcarbazepine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Oxcarbazepine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Oxcarbazepine Revenue (2017-2028) & (USD Million)
Figure 27. South America Oxcarbazepine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Oxcarbazepine Revenue (2017-2028) & (USD Million)
Figure 29. Global Oxcarbazepine Sales Market Share by Type (2017-2028)
Figure 30. Global Oxcarbazepine Revenue Market Share by Type (2017-2028)
Figure 31. Global Oxcarbazepine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Oxcarbazepine Sales Market Share by Application (2017-2028)
Figure 33. Global Oxcarbazepine Revenue Market Share by Application (2017-2028)
Figure 34. Global Oxcarbazepine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Oxcarbazepine Sales Market Share by Type (2017-2028)
Figure 36. North America Oxcarbazepine Sales Market Share by Application (2017-2028)
Figure 37. North America Oxcarbazepine Sales Market Share by Country (2017-2028)
Figure 38. North America Oxcarbazepine Revenue Market Share by Country (2017-2028)
Figure 39. United States Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Oxcarbazepine Sales Market Share by Type (2017-2028)
Figure 43. Europe Oxcarbazepine Sales Market Share by Application (2017-2028)
Figure 44. Europe Oxcarbazepine Sales Market Share by Country (2017-2028)
Figure 45. Europe Oxcarbazepine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Oxcarbazepine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Oxcarbazepine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Oxcarbazepine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Oxcarbazepine Revenue Market Share by Region (2017-2028)
Figure 55. China Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Oxcarbazepine Sales Market Share by Type (2017-2028)
Figure 62. South America Oxcarbazepine Sales Market Share by Application (2017-2028)
Figure 63. South America Oxcarbazepine Sales Market Share by Country (2017-2028)
Figure 64. South America Oxcarbazepine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Oxcarbazepine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Oxcarbazepine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Oxcarbazepine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Oxcarbazepine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Oxcarbazepine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Oxcarbazepine in 2021
Figure 76. Manufacturing Process Analysis of Oxcarbazepine
Figure 77. Oxcarbazepine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
